QUality of Life in pAtients With Mild to modeRate Active procTitis Treated

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

This national, observational and multicentre study aims at establishing a picture of real clinical practices management among patients treated with Pentasa®, according to the current therapeutic strategy in proctitis or distal proctosigmoiditis. This study should be able to provide data on patients' health related quality of life, compliance and efficacy in real clinical practice

See also
	Status	Clinical Trial	Phase
	Active, not recruiting	`NCT01586533` - Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis	Phase 2

NCT number	NCT02368743
Study type	Observational
Source	Ferring Pharmaceuticals
Contact
Status	Completed
Phase
Start date	December 2015
Completion date	January 2, 2018

QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa®) — QUARTZ

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms